2-Fluoro-3-(trifluoromethyl)benzonitrile, 97.0%, 25g

3-(Toluene-4-sulfonyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 1g

2-(4-(Benzyloxy)-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

4,4-DIMETHYL-1,2,3,4-TETRAHYDROISOQUINOLINE HCL, 97.0%, 1g

5-Bromo-4,6-dichloropyrimidine, 96.0%, 25g

Monohidrato de D(+)-maltosa, mínimo 92 %, para bioquímica, 250 g, envase de plástico.

5-(4-Ethylphenyl)-5-oxovaleric acid, 95.0%, 1g

(4S,5S)-4,5-Diphenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole, 98%, 250mg

6-Amino-2-methylthio-4[3H]pyrimidinone, 95.0%, 250mg

(S)-4-Oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic acid, 98%, 100mg

N1-(2-(Dimethylamino)ethyl)-N2,N2-dimethylethane-1,2-diamine, 98%, 10g

2-methyl-2-phenoxypropanoic acid, 95.0%, 5g

4'-Carboethoxy-2,2,2-trifluoroacetophenone, 97.0%, 5g